Outpatient/Ambulatory Health Services
HRSA Service Definition
Outpatient/Ambulatory Health Services are diagnostic and therapeutic services provided directly to a client by a licensed healthcare provider in an outpatient medical setting. Outpatient medical settings include clinics, medical offices, and mobile vans where clients do not stay overnight. Emergency room or urgent care services are not considered outpatient settings.
Allowable activities include:
- Medical history taking
- Physical examination
- Diagnostic testing, including laboratory testing
- Treatment and management of physical and behavioral health conditions
- Behavioral risk assessment, subsequent counseling, and referral
- Preventive care and screening
- Pediatric developmental assessment
- Prescription, and management of medication therapy
- Treatment adherence
- Education and counseling on health and prevention issues
- Referral to and provision of specialty care related to HIV diagnosis
Program Guidance:
Treatment Adherence services provided during an Outpatient/Ambulatory Health Service visit should be reported under the Outpatient/Ambulatory Health Services category whereas Treatment Adherence Services provided during a Medical Case Management visit should be reported in the Medical Case Management service category.
As part of Outpatient and Ambulatory Medical Care, provision of laboratory tests integral to the treatment of HIV infection and related complications.
Number of Clients Served, Units Provided, Expenditures,* Allocation*, and Over/Under-spending
Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Medical Care Clients | 11,011 | 11,176 | 11,056 | 11,617 | 10,848 | 11,078 | 10,911 |
Medical Care Units (Dr. visit) | 38,850 | 35,662 | 36,606 | 35,511 | 32,003 | 21,838 | 30,205 |
Medical Care Dollars | $7,227,633 | $7,104,406 | $7,362,705 | $7,328,009 | $6,786,955 | $6,874,190 | $6,847,595 |
Allocated Dollars | $7,152,427 | $7,162,288 | $7,055,207 | $6,952,646 | $6,915,452 | $6,900,099 | $6,965,625 |
Over/ Underspending | $75,206 over | $57,882 under | $307,498 over | $375,363 over | $128,497 under | $25,909 under | $118,030 under |
*Includes Minority AIDS Initiative (MAI) funding
Funding by Part, and info on any other payers
Total Part A Funds (Formula + Supp.) | MAI | Total Part B Funds (Formula + Supp. NJ) | Total Part B Funds (Formula + Supp. PA) | Total Part C EIS Funds (State & Local) | Total Part D Funds (State & Local) | Total Part F Funds | |
---|---|---|---|---|---|---|---|
Last Year Allocation | $6,600,170 | $365,454 | $812,384 | $4,759,759 | $2,481,614 | $930,000 | |
Current Allocation | $6,606,720 | $349,763 | $3,762,013 | $2,331,614 | $620,000 |
Consumer survey info 2017 n=392
n | Used in the last 12 months | Needed but did not get (last 12 months) | |
---|---|---|---|
Ambulatory Health Services | 242 | 93.8% | 6.2% |
Community Survey 2022 Service Responses n=236
I never personally needed this service | I needed this service and received it | I needed but did not get this service | I never heard of this service | |
---|---|---|---|---|
Ambulatory Health Services | 15.25% | 53.81% | 2.12% | 2.12% |
Unmet need
For the purposes of this document, need is based on the response of a consumer when asked if there was a service they needed. MMP interviews patients in care and asks consumers if they need a service and if they receive it. Client services unit data identifies needs at the time of initial intake.
2015-18 MMP Percent with a Need (weighted) | 2021 Client Services Unit Need at Intake | |
---|---|---|
Ambulatory Health Services | 7.6% | 22.8% |
Recipient Service Considerations
Ambulatory Health Services
Part A funds 24 HIV medical care programs in the EMA. These outpatient/ambulatory care providers are located in hospitals, comprehensive services agencies, Federally Qualified Health Centers and in the City of Philadelphia Health Centers.
Service utilization declined slightly this year, with 165 (-1.5%) fewer clients accessing Part A/MAI HIV medical services. Meanwhile, the number of Part A/MAI medical visits decreased by 1,663 (-5.1%) in comparison to FY 2021. There was a 0.4% decrease in expenditures.
VL Suppression in the EMA increased from 85% to 86% during this period, likely due to more viral load tests being conducted as patients continued to return to in-person visits.